Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

tags : Trial    symbols : BXRX    save search

Baudax Bio Announces Additional, Positive Top-Line Results From Phase 2 Randomized Clinical Trial of BX1000
Published: 2023-06-07 (Crawled : 13:20) - globenewswire.com
BXRX | $0.1864 -54.35% 330K twitter stocktwits trandingview |
Health Technology
| | O: 7.16% H: 5.23% C: -2.57%

bx1000 positive trial results phase 2
Baudax Bio Announces Positive Top-Line Final Results From Phase 2 Randomized Clinical Trial of BX1000
Published: 2023-04-25 (Crawled : 13:20) - biospace.com/
BXRX | $0.1864 -54.35% 330K twitter stocktwits trandingview |
Health Technology
| | O: 63.83% H: 12.66% C: -32.14%

bx1000 positive trial results phase 2
Baudax Bio to Host Key Opinion Leader Webinar to Discuss Results of Phase 2 BX1000 Trial
Published: 2023-04-24 (Crawled : 21:00) - globenewswire.com
BXRX | $0.1864 -54.35% 330K twitter stocktwits trandingview |
Health Technology
| | O: 63.83% H: 12.66% C: -32.14%

bx1000 trial results phase 2
Baudax Bio Announces Positive Results from 2nd Interim Analysis of Phase 2 Randomized Trial for BX1000
Published: 2023-03-27 (Crawled : 13:20) - biospace.com/
BXRX | $0.1864 -54.35% 330K twitter stocktwits trandingview |
Health Technology
| | O: 16.13% H: 16.11% C: 7.78%

bx1000 positive trial phase 2
Baudax Bio Announces Positive Outcome of Interim Analysis of Phase II Randomized Trial for BX1000
Published: 2023-01-24 (Crawled : 14:00) - biospace.com/
BXRX | $0.1864 -54.35% 330K twitter stocktwits trandingview |
Health Technology
| | O: 94.29% H: 12.58% C: -31.86%

bx1000 trial positive
Baudax Bio Initiates Phase II Clinical Trial Evaluating BX1000 in Patients Undergoing Surgery
Published: 2022-12-08 (Crawled : 14:20) - biospace.com/
BXRX | $0.1864 -54.35% 330K twitter stocktwits trandingview |
Health Technology
| | O: 4.15% H: 22.51% C: 15.95%

bx1000 trial
Baudax Bio Initiates Phase IV Clinical Trial Evaluating ANJESO® in Pediatric Patients Following Surgery
Published: 2022-03-08 (Crawled : 22:00) - globenewswire.com
BXRX | $0.1864 -54.35% 330K twitter stocktwits trandingview |
Health Technology
| | O: 1.27% H: 2.49% C: 1.25%

anjeso trial
Gainers vs Losers
67% 33%

Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M twitter stocktwits trandingview |
Finance

EGOX | $0.0515 43.06% 30.1% 330M twitter stocktwits trandingview |

OLB 4 | $0.33 -14.95% 25.53% 840K twitter stocktwits trandingview |
Technology Services

NVFY | $2.77 31.28% 23.83% 33M twitter stocktwits trandingview |
Consumer Durables

ZCMD | $1.87 28.97% 22.46% 31M twitter stocktwits trandingview |
Commercial Services

RCON | $0.1112 13.01% 21.28% 1.7M twitter stocktwits trandingview |
Distribution Services

INSG | $3.03 25.21% 20.13% 330K twitter stocktwits trandingview |
Electronic Technology

GCTK | $0.8191 22.25% 18.2% 190K twitter stocktwits trandingview |
Manufacturing

WLGS | $0.59 18.0% 17.9% 2.3M twitter stocktwits trandingview |

ASNS | $0.828 21.75% 17.86% 18K twitter stocktwits trandingview |


Your saved searches
Save your searches and get alerts when important news are released.